Navigation Links
Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
Date:12/6/2007

CORONA, Calif., Dec. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has reached a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis") on outstanding patent litigation related to Watson's generic version of Exelon(R) (rivastigmine tartrate) capsules.

Under the terms of the settlement agreement, Novartis has granted Watson a license to its U.S. patents covering Exelon(R) for a generic version of Exelon(R). The agreement generally provides that Watson will not commence marketing its generic equivalent product until sometime prior to the expiration of the patents covering Exelon(R). The specific date on which Watson may launch its generic product and other details concerning the settlement have not been disclosed. Watson's Abbreviated New Drug Application for its generic version of Exelon(R) has been tentatively approved by the U.S. Food and Drug Administration.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the difficulty of predicting the timing and outcome of litigation; risks that
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
7. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
8. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
10. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
11. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 The American ... new volunteer network “ABTA CommYOUnity™” during its annual patient ... pivotal time for the brain tumor community as we ... patient and caregiver support services and funding brain tumor ... are passionate about brain tumor awareness and getting our ...
(Date:7/25/2014)... IL (PRWEB) July 25, 2014 There are ... and 500 diagnosed each day. Though when someone hears the ... confused and are unsure of the next step and where ... helping people figure out that next step by providing and ... this more than Brian Olson, member of the ABTA’s Board ...
(Date:7/25/2014)... Progress in understanding the molecular genetics of ... promising brain tumor treatments, according to Patrick Wen, MD, ... Center for Neuro-Oncology, Dana-Farber Cancer Institute. , At the ... Conference in Chicago, July 25-26, Dr. Wen will moderate ... impacting the development of new treatments and advancing strategies ...
(Date:7/25/2014)... According to the new report "Sapphire Technology Market by ... Analysis & Forecast to 2013 - 2020", the global ... Billion by 2020 at a CAGR of 12.31%, whereas ... to reach $6.17 billion by 2020 at a CAGR ... and geography. , Browse more than 65 market data ...
(Date:7/25/2014)... CA (PRWEB) July 25, 2014 Splashtop, ... WorkPlace Partner Program . Splashtop Business and Splashtop Enterprise ... and will leverage the MaaS360 WorkPlace SDK to ... , Splashtop Business and Splashtop Enterprise offer secure remote ... device. High performance, ease of use, collaborative ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 2Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4
... With audience members cheering and,famous Chicago chefs watching ... for the finalists at Consorta,s Battle of the Hospital,Chefs. ... the organic cucumbers he,serves the patients at Saint Mary,s ... event,s Gold Chef Award, becoming the reigning champion of,chefs ...
... systemic fibrosis (NSF) is a newly identified debilitating and ... is characterized by a thickening and hardening of the ... it can also affect internal organs and can progress ... within a few weeks. Although it is not clear ...
... and problems in ones neighborhood are associated with greater ... in Vancouver, Canada. , Social environment has long been ... in youth, but few studies have empirically tested social ... their implications for childhood asthma. , Edith Chen, Ph.D., ...
... PHOENIX, Sept. 27 Matrixx Initiatives, Inc.,(Nasdaq: ... and,markets products that provide consumers with "Better Ways ... 3, 2007, at the,William Blair & Company Small-Cap ... presenting at 3:20 p.m. ET. To listen to ...
... for the pub musicians who play them, Irish researchers say ... is not only salve for the lungs, it is music to ... air quality in Irish pubs as well as the health of ... play them, research suggests. , "Research to date looking at ...
... Non Media types, its,hard not to notice that Britney has been ... something is definitely going on with our,Famed Star. On a ... makeover and when asked what type of smile she wanted, she ... celebrity stars and right,on top of that pile was ... you ...
Cached Medicine News:Health News:National Battle of the Hospital Chefs Cooks Up a Winner 2Health News:Higher death rates in kidney patients with newly recognized disease 2Health News:Higher death rates in kidney patients with newly recognized disease 3Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3Health News:Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference 2Health News:Accordions Breathe Easier Since Smoking Ban 2
(Date:7/25/2014)... LAS VEGAS , July 25, 2014 GrowBLOX ... of a binding Memorandum of Understanding ("MOU") with LaurelCo, LLC, ... to pursue the acquisition of both cultivation and dispensary medical ... . Pursuant to the MOU, GBLX will acquire a 20% ... use our proprietary GrowBLOX TM growing chambers, as well ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... MEXICO CITY , July 25, 2014 ... a Latin American healthcare sciences publisher, launched a library ... on conditions such as cancer and heart disease. Healthcare ... most up-to-date information to deliver better patient care. ... rapidly, with many relying on smartphones and tablets to ...
Breaking Medicine Technology:GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Acsis Addresses Questions on the Modern Supply Chain 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4
... Pfizer Inc. has agreed to provide the University ... set of electrocardiographic data that will help researchers develop ... This is the first time a major pharmaceutical ... one of its drug safety trials, including data from ...
... Mass., Jan. 12 Solace Pharmaceuticals, a,private ... pain, announced the initiation of a proof-of-concept ... neuralgia (PHN). PHN, a painful,complication of shingles, ... the,US alone. The clinical trial is an ...
Cached Medicine Technology:Pfizer Contributes Critical Data to URMC Drug Safety Initiative 2Pfizer Contributes Critical Data to URMC Drug Safety Initiative 3Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia 2
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: